Biomarkers and surrogate end points in clinical trials of tuberculosis treatment

被引：5
|
作者：
Davies, Geraint Rhys
Phillips, Patrick P. J.
Nunn, Andrew J.
机构：
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[2] MRC, Clin Trials Unit, London, England
来源：
JOURNAL OF INFECTIOUS DISEASES | 2007年 / 196卷 / 04期
关键词：
D O I：
10.1086/519744
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [31] Surrogate End Points in Secondary Analyses of Cardiovascular Trials
    Buhr, Kevin A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (04) : 343 - 350
  • [32] On the use of surrogate end points in randomized trials - Comments
    Prentice, RL
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2000, 163 : 26 - 27
  • [33] Imaging Surrogate End Points in Heart Failure Trials
    Bettari, Luca
    Borges-Neto, Salvador
    HEART FAILURE CLINICS, 2011, 7 (04) : 509 - +
  • [34] Microbiologic surrogate end points in infectious diseases: Example of acute clinical trials of otitis media trials
    Powers, JH
    PHARMACOTHERAPY, 2005, 25 (12): : 109S - 123S
  • [35] Challenges of defining reliable clinical surrogate end points in haemophilia trials: a critical review
    Amby, Lene Klixbull
    Seremetis, Stephanie
    Obergfell, Achim
    Bjerre, Jens
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (07) : 488 - 493
  • [36] Use of surrogate end points for prostate cancer-related mortality in clinical trials
    不详
    Nature Clinical Practice Oncology, 2009, 6 (2): : 61 - 62
  • [37] Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: An update
    Kelloff, GJ
    Bast, RC
    Coffey, DS
    D'Amico, AV
    Kerbel, RS
    Park, JW
    Ruddon, RW
    Rustin, GJS
    Schilsky, RL
    Sigman, CC
    Woude, GFV
    CLINICAL CANCER RESEARCH, 2004, 10 (11) : 3881 - 3884
  • [38] Role of biochemical Alzheimer's disease biomarkers as end points in clinical trials
    Siemers, Eric
    DeMattos, Ronald B.
    May, Patrick C.
    Dean, Robert A.
    BIOMARKERS IN MEDICINE, 2010, 4 (01) : 81 - 89
  • [39] Biomarkers as end points in clinical trials of severe sepsis: A garden of forking paths
    Salluh, Jorge I. F.
    Povoa, Pedro
    CRITICAL CARE MEDICINE, 2010, 38 (08) : 1749 - 1751
  • [40] Biomarkers and surrogate endpoints in glaucoma clinical trials
    Medeiros, Felipe A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (05) : 599 - 603
12345